Skip to main content
Fig. 3 | Thrombosis Journal

Fig. 3

From: Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study

Fig. 3

A. The percentage of MACEs in different subgroups according to the combination of PCSK9 and PT. B. Multiple Cox regression analysis in different subgroups. Adjusted model was adjusted for age, gender, CAD, diabetes, family history of CAD, TC, LDL, HbA1C, fibrinogen. MACEs, major adverse cardiovascular events; PCSK9, proprotein convertase subtilisin/kexin type 9; PT, prothrombin time; HR, hazard ratio; CI, confidence interval; CAD, coronary artery disease; TC, total cholesterol; HDL-C, LDL-C, low-density lipoprotein cholesterol; HbA1C, hemoglobin A1C

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us